Bioxcel therapeutics, inc. (BTAI)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17
ASSETS
Current assets
Cash and cash equivalents

80,079

32,426

40,252

29,965

36,296

42,565

47,122

50,349

55,465

887

Prepaid expenses and other current assets

3,519

1,681

1,109

1,500

1,783

491

467

669

808

3

Due from Parent

-

-

-

46

-

115

49

70

44

-

Total current assets

83,598

34,107

41,361

31,511

38,079

43,171

47,638

51,088

56,317

890

Deferred offering costs

-

-

-

378

-

-

-

-

-

-

Deferred offering expenses

-

-

-

-

-

-

-

-

-

461

Property and equipment, net

1,010

1,041

1,086

1,092

905

327

177

122

4

4

Operating lease right-of-use asset

1,153

1,193

1,199

1,246

1,293

-

-

-

-

-

Other assets

51

51

51

51

51

51

51

-

-

-

Total assets

85,812

36,392

43,697

34,278

40,328

43,549

47,866

51,210

56,321

1,355

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable

6,733

4,953

4,238

3,979

2,128

1,604

1,213

889

3,935

444

Accrued expenses

3,600

3,120

3,387

3,371

3,348

3,056

830

500

267

1,015

Due to related party

-

-

-

-

-

-

-

-

13

-

Payable to Parent for services

-

-

-

-

-

-

-

-

-

67

Note payable to Parent

-

-

-

-

-

-

-

-

-

371

Due to Parent

-

64

59

-

392

-

-

-

-

440

Other current liabilities

1,932

331

522

659

939

-

-

-

-

-

Total current liabilities

12,265

8,468

8,206

8,009

6,807

4,660

2,043

1,389

4,215

2,337

Operating lease liability

961

1,029

1,071

1,112

1,153

-

-

-

-

-

Total liabilities

13,226

9,497

9,277

9,121

7,960

4,660

2,043

1,389

4,215

2,337

Commitments and contingencies

-

-

-

-

-

-

-

0

0

-

Stockholders' equity
Preferred stock, $0.001 par value, 10,000,000 shares authorized; no shares issued or outstanding

-

-

-

-

-

-

0

0

0

-

Common stock, $0.001 par value, 50,000,000 shares authorized; 20,182,382 and 18,087,382 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

20

18

18

16

16

16

16

16

16

10

Additional paid-in-capital

144,165

83,565

82,815

64,536

63,276

62,593

62,452

61,563

60,822

3,458

Accumulated deficit

-71,599

-56,688

-48,413

-39,395

-30,924

-23,720

-16,645

-11,758

-8,732

-4,450

Total stockholders' equity

72,586

26,895

34,420

25,157

32,368

38,889

45,823

49,821

52,106

-982

Total liabilities and stockholders' equity

85,812

36,392

43,697

34,278

40,328

43,549

47,866

51,210

56,321

1,355